Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: VERSATOPE THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-04 to 2025-04-24
Current total value of award: $16754609.82
Description: DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIOTHREAT AGENTS, ANTIMICROBIAL-RESISTANT INFECTIONS AND EMERGING INFECTIOUS DISEASES.